While manipulation of Ang (1–7) has enormous therapeutic potential for stroke and other diseases, it is rapidly degraded in the stomach when administered orally; therefore, Ang (1–7) is considered orally inactive. The gene discussed is ANGPT1; the disease is stroke disorder.